When using dopps slides
This presentation is the property of its rightful owner.
Sponsored Links
1 / 21

When Using DOPPS Slides PowerPoint PPT Presentation


  • 108 Views
  • Uploaded on
  • Presentation posted in: General

When Using DOPPS Slides. DOPPS Slide Use Guidelines. C-Reactive Protein (CRP) and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Introduction. DOPPS Background (1). DOPPS Background (2). Methods.

Download Presentation

When Using DOPPS Slides

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


When using dopps slides

When Using DOPPS Slides


Dopps slide use guidelines

DOPPS Slide Use Guidelines


When using dopps slides

C-Reactive Protein (CRP) and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)


Introduction

Introduction


Dopps background 1

DOPPS Background (1)


Dopps background 2

DOPPS Background (2)


Methods

Methods


Table 1 baseline patient characteristics by crp level above and below 3 0 mg l japan only 1

Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (1)


Table 1 baseline patient characteristics by crp level above and below 3 0 mg l japan only 2

Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (2)


Table 1 baseline patient characteristics by crp level above and below 3 0 mg l japan only 3

Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (3)


When using dopps slides

Table 2. Baseline Characteristics for Patients by High vs Low Facility Percentage CRP Measurement, all DOPPS Countries Except US and Canada (1)


When using dopps slides

Table 2. Baseline Demographics for Patients by High vs Low Facility Percentage CRP Measurement, all Countries Except US and Canada (2)


When using dopps slides

Table 2. Baseline Demographics for Patients by High vs Low Facility Percentage CRP Measurement, all Countries Except US and Canada (3)


Table 3 mortality hazards ratio hr by facility percent of patients with crp measurement

Table 3. Mortality Hazards Ratio (HR) by Facility Percent of Patients with CRP Measurement


Conclusions

Conclusions


Acknowledgements

Acknowledgements


  • Login